More recently, Amgen has assembled a multidisciplinary group of chemists and biologists who together approach the challenge of drug discovery using multiple potential therapeutic modalities. This novel approach allows us to choose the best target for attacking a disease and to use the modality most likely to affect that target. The research program has grown spectacularly, yielding a heightened understanding of human disease, and innovative new approaches to improving human health.
Our R&D engine is powered by dedicated, creative scientists who are attracted to Amgen by our intellectual vigor, our commitment to world-class research, and most importantly, by the many opportunities we offer to make a dramatic difference in the lives of patients.
